Submitted by Anonymous (not verified) on 10 September 2025 - 15:18
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 35, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 35, Status: Authorised